arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

NATURES SUNSHINE PRODUCTS INC

NATR
$16.28 ▼ -4.04 (-19.86%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

NATURES SUNSHINE PRODUCTS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $285.3M
Dividend Yield
Revenue Growth 8.5%
Op. Margin 7.8%
ROIC None
FCF / Share $-0.25
Trailing P/E 56.1x
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$122.89M
↑ +8.5%
Net Income Profit after all expenses
$5.12M
↑ +7.8%
Operating Margin Operating profit as % of sales
7.8%
↑ +80.7% 43th
FCF / Share Free cash flow per share
$-0.25
↓ -125.9%
Long-Term Debt Long-term obligations
$2.11M
↑ +79.5%

Health Breakdown

Profitability
46
Financial Health
97
Cash Quality
79

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share
-100.0% YoY

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters